Suppr超能文献

从人体受控感染研究中退出的权利:理由与回避。

The right to withdraw from controlled human infection studies: Justifications and avoidance.

机构信息

Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania.

出版信息

Bioethics. 2020 Oct;34(8):833-848. doi: 10.1111/bioe.12704. Epub 2020 Jan 24.

Abstract

The right to withdraw from research without penalty is well established around the world. However, it has been challenged in some corners of bioethics based on concerns about various harms-to participants, to scientific integrity, and to research bystanders-that may stem from withdrawal. These concerns have become particularly salient in emerging debates about the ethics of controlled human infection (CHI) studies in which participants are intentionally infected with pathogens, often in inpatient settings with extensive follow-up. In this article, I provide support for preserving the right to withdraw from research without penalty and demonstrate that it is also typically justified in the specific context of CHI studies. The right is well aligned with individual freedoms outside the research setting, where autonomous individuals are permitted to engage in behaviors that will foreseeably cause them harm; where they cannot be compelled to satisfy contracts for their services, nor penalized for failure to do so; and where their behavior is not constrained by public health authorities except in extreme circumstances. These freedoms are supported by U.S. law, as well as by ethical analysis that is more globally relevant. The problems associated with the right to withdraw, however, remain. The best approach to addressing them is not to restrict the right but rather to avoid initiating research when withdrawal would be especially problematic. If research proceeds, steps can still be taken to minimize participant withdrawal without infringing the right. Investigators can avoid participant surprise through informed consent focused on a study's most burdensome aspects and promote study completion through financial incentives. Should participants nonetheless seek to withdraw, investigators may attempt to persuade them not to do so by encouraging consideration of the range of potential harms that may result. Researchers conducting CHI studies and other research from which withdrawal might be especially problematic should prepare for the possibility of participant withdrawal, respect participant requests to withdraw without penalty, and incorporate various measures to avoid such requests.

摘要

退出研究而不受惩罚的权利在世界范围内已得到确立。然而,基于对各种可能因退出而产生的危害(对参与者、对科学诚信、对研究旁观者的危害)的担忧,这一权利在某些生物伦理领域受到了挑战。这些担忧在关于受控人体感染(CHI)研究的伦理新兴辩论中变得尤为突出,在这些研究中,参与者被故意感染病原体,通常在住院环境中进行广泛的随访。在本文中,我支持保留退出研究而不受惩罚的权利,并证明在 CHI 研究的具体背景下,这一权利也是合理的。该权利与研究环境之外的个人自由是一致的,在研究环境之外,自主的个人被允许从事那些可以预见会对他们造成伤害的行为;他们不能被迫履行服务合同,也不能因未能履行合同而受到惩罚;只有在极端情况下,他们的行为才不受公共卫生当局的限制。这些自由得到了美国法律以及更具全球相关性的伦理分析的支持。然而,与退出权相关的问题仍然存在。解决这些问题的最佳方法不是限制权利,而是在退出可能特别成问题时避免启动研究。如果研究继续进行,可以采取措施在不侵犯权利的情况下尽量减少参与者的退出。调查人员可以通过关注研究中最繁琐的方面的知情同意书来避免参与者感到意外,并通过经济激励来促进研究完成。尽管如此,如果参与者仍试图退出,调查人员可以通过鼓励他们考虑可能产生的各种潜在危害来试图说服他们不要退出。进行 CHI 研究和其他可能特别容易出现退出问题的研究的研究人员应做好参与者退出的准备,尊重参与者不受惩罚地退出的请求,并采取各种措施避免此类请求。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验